PB2095 OUTCOME AFTER AZACITITINE TREATMENT IN PATIENTS WITH HIGH-RISK MYEOLODYSPLASTIC SYNDROME, CHRONIC MYELOMONOCYTIC LEUKEMIA TYPE 2 AND ACUTE MYELOID LEUKEMIA–A SINGLE CENTER EXPERIENCE

Autor:	A. Nedeva, T. Kuncheva, I. Kindekov, Viktoria Varbanova, N. Petkova, M. Anastasova-Postadzhiyan, J. Raynov, D. Popova, E. Vikentieva, L. Mitev, Y. Kuyumdzhieva, I. Nicolov
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine medicine Chronic myelomonocytic leukemia Myeloid leukemia In patient Hematology Single Center business medicine.disease
Zdroj:	HemaSphere. 3:943-944
ISSN:	2572-9241
DOI:	10.1097/01.hs9.0000566864.23509.c7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::cdbc6864d4d39012904b4cd04b59c183 https://doi.org/10.1097/01.hs9.0000566864.23509.c7 Zobrazit plný text záznamu Plný text